Eric Dobmeier
Director/Board Member at ATARA BIOTHERAPEUTICS, INC.
Net worth: 354 428 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Srini Akkaraju Akkaraju | M | 56 |
Chinook Therapeutics U.S., Inc.
 Chinook Therapeutics U.S., Inc. Information Technology ServicesTechnology Services Chinook Therapeutics U.S., Inc. operates as a development stage company. The company is headquartered in Seattle, WA. | 21 years |
| Eric Hyllengren | M | 49 | 6 years | |
| Michelle Griffin | F | 58 | 5 years | |
| Daniel Welch | M | 66 | 18 years | |
| Pascal Touchon | M | 61 | 5 years | |
| Carol Gallagher | M | 59 | 11 years | |
| Jerel Davis | M | 47 |
Chinook Therapeutics U.S., Inc.
Chinook Therapeutics U.S., Inc. Information Technology ServicesTechnology Services Chinook Therapeutics U.S., Inc. operates as a development stage company. The company is headquartered in Seattle, WA. | 6 years |
| Raymond Stevens | M | 60 | 5 years | |
| Kenneth Hoberman | M | 59 | 11 years | |
| Joanne Waldstreicher | M | 63 | 2 years | |
| Jun Yoon | M | 46 | 5 years | |
| Katey Owen | M | 55 | 3 years | |
| Stacy Taylor | F | 64 | 5 years | |
| Ameet Mallik | M | 51 | 3 years | |
| Maria Grazia Roncarolo | M | 69 | 4 years | |
| Jeffrey Levitt | M | - | 6 years | |
| Ted Love | M | 65 | 1 years | |
| Ramy Farid | M | 59 | 5 years | |
| David Gionco | M | 63 | 10 years | |
| Michael Pellini | M | 58 | 6 years | |
| Matthew Fust | M | 59 | 10 years | |
| Sharon Tetlow | F | 64 | 2 years | |
| William Heiden | M | 64 | 9 years | |
| Dan Maziasz | M | - | 6 years | |
| Tony Peng | M | - | - | |
| Ying Li Ma | M | 50 | 2 years | |
| Xi Chen Lin | M | 50 | 5 years | |
| Natasha Hernday | F | 52 | 13 years | |
| Mark Bach | M | 67 | 3 years | |
| Jill Henrich | F | 61 | - | |
| Francis Lo | M | 43 | 5 years | |
| Lani Ibarra | F | - | - | |
| Anhco Nguyen | M | 51 | 3 years | |
| K. Murugan | M | 49 | 4 years | |
| Karen S. Wright | F | 69 | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| R. Adams | M | 57 | 3 years | |
| Isaac E. Ciechanover | M | 53 | 7 years | |
| Felix Baker | M | 55 | 20 years | |
| Mina Kim | F | 50 | 1 years | |
| Darren Cline | M | 59 | 9 years | |
| Edmon R. Jennings | M | 75 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 6 years |
| Joshua Brumm | M | 46 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 years |
| Vaughn Himes | M | 63 | 14 years | |
| Joseph Newell | M | 54 | 5 years | |
| Colin Hislop | M | 66 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 1 years |
| Andris A. Zoltners | M | 78 | 11 years | |
| John Orwin | M | 59 | 9 years | |
| John Craighead | M | - | - | |
| Nancy Hill | F | 60 | 8 years | |
| Andrew King | M | 44 | 4 years | |
| Charles Sang | M | 56 | 7 years | |
| Kirk D. Schumacher | M | - | 11 years | |
| David Goel | M | 54 | 5 years | |
| Marcos Milla | M | 61 | 1 years | |
| Larry K. Benedict | M | 63 | 8 years | |
| Robert Azelby | M | 56 | - | |
| Charles Romp | M | - | 13 years | |
| Christopher Boerner | M | 53 | 5 years | |
| Beth Seidenberg | M | 67 | 11 years | |
| James Kyle Bryan | M | - | - | |
| Dolca Thomas | M | 53 | 3 years | |
| Shane Ward | M | 49 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 3 years |
| Krishnan Mahesh /davita/ | - | - | - | |
| Tina Gullotta | F | 50 | 4 years | |
| Tony Sun | M | 52 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 5 years |
| Roy Baynes | M | 69 | 4 years | |
| Shay Shemesh | M | 41 | 5 years | |
| Stephen Hall | M | 73 | - | |
| Franklin Berger | M | 74 | 10 years | |
| Jean Liu | F | 55 | 9 years | |
| Leslie Trigg | F | 53 | - | |
| Kevin Conroy | M | 58 | 4 years | |
| Obi Greenman | M | 57 | 13 years | |
| Heather Turner | F | 51 | 3 years | |
| J. Buchi | M | 69 | 4 years | |
| Eckard Weber | M | 73 | 2 years | |
| David Gryska | M | 68 | 18 years | |
| Joel Marcus | M | 76 | 6 years | |
| H. Perry Fell | M | - | 7 years | |
| Kenneth Lee | M | 76 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | - |
| Kevin Haas | M | 59 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 years |
| John McLaughlin | M | 72 | 9 years | |
| John Varian | M | 64 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 years |
| Douglas Williams | M | 66 | 3 years | |
| Robert Hoffman | M | 58 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | - |
| Ronald Renaud | M | 55 | 2 years | |
| John F. McGrath | M | 59 | 6 years | |
| Nancy Simonian | M | 63 | 11 years | |
| Ross Haghighat | M | 60 | 14 years | |
| Robert Gut | M | 59 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 1 years |
| Jonathan Drachman | M | 62 | 14 years | |
| Eric Feldman | M | 68 | 3 years | |
| Bruce J. Seeley | M | 59 | 3 years | |
| Pamela A. Trail | M | 68 | 1 years | |
| Brandi Robinson | F | - | 2 years | |
| Eric Sievers | M | 60 | 9 years | |
| Todd Simpson | M | 63 | 18 years | |
| Amy P. Sing | M | 65 | 4 years | |
| Andrew Sandler | M | 58 | 4 years | |
| Iqbal S. Grewal | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Dobmeier
- Personal Network
